As of January 2025, Orchid Pharma has a market cap of $1.07B. This makes Orchid Pharma the world's 7439th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $664.76M | 56.65% |
2023 | $424.37M | 95.71% |
2022 | $216.83M | -7.81% |
2021 | $235.21M | 220.41% |
2020 | $73.41M | 2161.47% |
2019 | $3.25M | 13.54% |
2018 | $2.86M | -74.33% |
2017 | $11.14M | -30.87% |
2016 | $16.11M | -58.54% |
2015 | $38.86M | 0.38% |
2014 | $38.71M | -1.37% |
2013 | $39.25M | -34.59% |
2012 | $60.01M | -20.45% |
2011 | $75.43M | -58.32% |
2010 | $180.98M | 65.36% |
2009 | $109.44M | 100.49% |
2008 | $54.59M | -67.96% |
2007 | $170.38M | 46.02% |
2006 | $116.68M | -18.87% |
2005 | $143.81M | 22.44% |
2004 | $117.45M | 14.25% |
2003 | $102.80M | 232.75% |
2002 | $30.89M | - |